Kaplan Matthew L. - Insider Non-Derivative Transactions at Nuvectis Pharma, Inc. (NVCT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 5, 2025, Kaplan Matthew L.'s relationship to Nuvectis Pharma, Inc. (NVCT) is Director, and currently has 124,760 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NVCT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kaplan Matthew L. - Insider Non-Derivative Transactions of NVCT Common Stock

Kaplan Matthew L. - Insider Non-Derivative Transactions at NVCT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 6, 2025	P -- (Common Stock)	11000	5.84	124760
Jun 13, 2025	Acquisition -- (Common Stock)	30000	0	113760
Jun 14, 2024	Acquisition -- (Common Stock)	30000	0	83760
Jun 17, 2023	Acquisition -- (Common Stock)	18000	0	53760